Authors: Filleur, S Volpert, OV Degeorges, A Voland, C Reiher, F Clezardin, P Bouck, N Cabon, F

Citation: S. Filleur et al., In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects, GENE DEV, 15(11), 2001, pp. 1373-1382

Authors: Thalmann, GN Sikes, RA Wu, TT Degeorges, A Chang, SM Ozen, M Pathak, S Chung, LWK

Citation: Gn. Thalmann et al., LNCaP progression model of human prostate cancer: Androgen-independence and osseous metastasis, PROSTATE, 44(2), 2000, pp. 91-103

Authors: Degeorges, A Wang, F Frierson, HF Seth, A Sikes, RA

Citation: A. Degeorges et al., Distribution of IGFBP-rP1 in normal human tissues, J HIST CYTO, 48(6), 2000, pp. 747-754

Authors: Dejong, V Degeorges, A Filleur, S Ait-Si-Ali, S Mettouchi, A Bornstein, P Binetruy, B Cabon, F

Citation: V. Dejong et al., The Wilms' tumor gene product represses the transcription of thrombospondin 1 in response to overexpression of c-Jun, ONCOGENE, 18(20), 1999, pp. 3143-3151

Authors: Hyytinen, ER Frierson, HF Sipe, TW Li, CL Degeorges, A Sikes, RA Chung, LWK Dong, JT

Citation: Er. Hyytinen et al., Loss of heterozygosity and lack of mutations of the XPG/ERCC5 DNA repair gene at 13q33 in prostate cancer, PROSTATE, 41(3), 1999, pp. 190-195

Authors: Degeorges, A Wang, F Frierson, HF Seth, A Chung, LWK Sikes, RA

Citation: A. Degeorges et al., Human prostate cancer expresses the low affinity insulin-like growth factor binding protein IGFBP-rP1, CANCER RES, 59(12), 1999, pp. 2787-2790